SEARCH

SEARCH BY CITATION

References

  • 1
    Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult lung and heart-lung transplantation report–2009. J Heart Lung Transplant 2009; 28: 10311049.
  • 2
    Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Lynch JP, Belperio JA. Chronic allograft rejection: Epidemiology, diagnosis, pathogenesis, and treatment Semin Respir Crit Care Med. 2010; 31: 189207.
  • 3
    Glanville AR. Bronchoscopic monitoring after lung transplantation Semin Respir Crit Care Med. 2010; 31: 208221.
  • 4
    Agostini C, Calabrese F, Rea F, et al. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 17031711.
  • 5
    Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169: 10371049.
  • 6
    Belperio JA, Keane MP, Burdick MD, et al. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003; 171: 48444852.
  • 7
    Keane MP, Gomperts BN, Weigt S, et al. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol 2007; 178: 511519.
  • 8
    Belperio JA, Keane MP, Burdick MD, et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001; 108: 547556.
  • 9
    Flesch-Janys D, Steindorf K, Gurn P, Becher H. Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and standardized mortality ratio analysis of cancer mortality by dose in an occupationally exposed cohort. Environ Health Perspect 1998; 106(Suppl 2): 655662.
  • 10
    Frost-Pineda K, Liang Q, Liu J, et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 2011; 3: 182193.
  • 11
    Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006; 15: 732739.
  • 12
    Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 2010;45: 371379.
  • 13
    Ling Y, Pong T, Vassiliou CC, Huang PL, Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol 2011; 3: 273–237.
  • 14
    Harris S, Coupes BM, Roberts SA, Roberts IS, Short CD, Brenchley PE. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 2007; 20: 177185.
  • 15
    Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 34983506.
  • 16
    Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 19111920.
  • 17
    Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779787.
  • 18
    Sadeghi M, Daniel V, Naujokat C, et al. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients. Clin Transplant 2010;24: 415423.
  • 19
    Mertens M, Singh JA. Anakinra for rheumatoid arthritis: A systematic review. J Rheumatol 2009; 36: 11181125.
  • 20
    Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008; 177: 10331040.